5-1280013-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_198253.3(TERT):c.1950+145A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.429 in 1,079,128 control chromosomes in the GnomAD database, including 102,532 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 18906 hom., cov: 34)
Exomes 𝑓: 0.42 ( 83626 hom. )
Consequence
TERT
NM_198253.3 intron
NM_198253.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.819
Publications
22 publications found
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
- pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dyskeratosis congenita, autosomal dominant 2Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
- acute myeloid leukemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma, cutaneous malignant, susceptibility to, 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 5-1280013-T-C is Benign according to our data. Variant chr5-1280013-T-C is described in ClinVar as Benign. ClinVar VariationId is 1267625.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TERT | NM_198253.3 | c.1950+145A>G | intron_variant | Intron 4 of 15 | ENST00000310581.10 | NP_937983.2 | ||
| TERT | NM_001193376.3 | c.1950+145A>G | intron_variant | Intron 4 of 14 | NP_001180305.1 | |||
| TERT | NR_149162.3 | n.2029+145A>G | intron_variant | Intron 4 of 12 | ||||
| TERT | NR_149163.3 | n.2029+145A>G | intron_variant | Intron 4 of 12 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TERT | ENST00000310581.10 | c.1950+145A>G | intron_variant | Intron 4 of 15 | 1 | NM_198253.3 | ENSP00000309572.5 |
Frequencies
GnomAD3 genomes AF: 0.487 AC: 74016AN: 152026Hom.: 18867 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
74016
AN:
152026
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.419 AC: 388845AN: 926984Hom.: 83626 AF XY: 0.418 AC XY: 199137AN XY: 476470 show subpopulations
GnomAD4 exome
AF:
AC:
388845
AN:
926984
Hom.:
AF XY:
AC XY:
199137
AN XY:
476470
show subpopulations
African (AFR)
AF:
AC:
15453
AN:
23126
American (AMR)
AF:
AC:
12385
AN:
40196
Ashkenazi Jewish (ASJ)
AF:
AC:
9611
AN:
21058
East Asian (EAS)
AF:
AC:
13725
AN:
36670
South Asian (SAS)
AF:
AC:
27822
AN:
69798
European-Finnish (FIN)
AF:
AC:
20903
AN:
45682
Middle Eastern (MID)
AF:
AC:
1488
AN:
3272
European-Non Finnish (NFE)
AF:
AC:
269055
AN:
644830
Other (OTH)
AF:
AC:
18403
AN:
42352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11515
23030
34545
46060
57575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6400
12800
19200
25600
32000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.487 AC: 74109AN: 152144Hom.: 18906 Cov.: 34 AF XY: 0.482 AC XY: 35877AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
74109
AN:
152144
Hom.:
Cov.:
34
AF XY:
AC XY:
35877
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
27638
AN:
41486
American (AMR)
AF:
AC:
5706
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1625
AN:
3468
East Asian (EAS)
AF:
AC:
2057
AN:
5164
South Asian (SAS)
AF:
AC:
1917
AN:
4834
European-Finnish (FIN)
AF:
AC:
4867
AN:
10598
Middle Eastern (MID)
AF:
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28704
AN:
67990
Other (OTH)
AF:
AC:
1048
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1905
3810
5714
7619
9524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1585
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.